BSX vs. STE

In the year-to-date period, BSX achieves a 56.46% return, which is significantly higher than STE's -0.57% return. Over the past 10 years, BSX has outperformed STE with an annualized return of 21.53%, while STE has yielded a comparatively lower 14.67% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and STERIS plc (STE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BSX Sharpe Ratio is 3.92, which is higher than the STE Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of BSX and STE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BSX has not paid dividends to shareholders, while STE's dividend yield for the trailing twelve months is around 1.24%.

The maximum BSX drawdown since its inception was -89.15%, which is greater than STE's maximum drawdown of -77.21%. Use the drawdown chart below to compare losses from any high point for BSX and STE. For additional features, visit the drawdowns tool.

The current volatility for Boston Scientific Corporation (BSX) is 5.84%, while STERIS plc (STE) has a volatility of 7.32%. This indicates that BSX experiences smaller price fluctuations and is considered to be less risky than STE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Boston Scientific Corporation and STERIS plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.